WallStreetZenWallStreetZen

NASDAQ: SBFM
Sunshine Biopharma Inc Stock

$0.08-0.01 (-11.11%)
Updated Apr 12, 2024
Why Price Moved
SBFM Price
$0.08
Fair Value Price
N/A
Market Cap
$7.96M
52 Week Low
$0.04
52 Week High
$1.40
P/E
-0.42x
P/B
0.38x
P/S
0.27x
PEG
N/A
Dividend Yield
N/A
Revenue
$24.09M
Earnings
-$4.51M
Gross Margin
34.6%
Operating Margin
-16.49%
Profit Margin
-18.7%
Debt to Equity
0.29
Operating Cash Flow
-$9M
Beta
0.63
Next Earnings
May 9, 2024
Ex-Dividend
N/A
Next Dividend
N/A

SBFM Overview

Sunshine Biopharma Incorporated is a pharmaceutical company focused on the research and development of anticancer drugs. The company is developing Adva-27a to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other cancers. The drug is also intended to treat multidrug resistant cancers, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine cancer. If offers SBFM-PL4, an anti-coronavirus treatment. It also manufactures and distributes a Calcium-Vitamin D supplement called Essential-9. Sunshine was incorporated in 2014 and is headquartered in Pointe-Claire, Quebec, Canada.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SBFM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SBFM is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SBFM is good value based on its book value relative to its share price (0.38x), compared to the US Drug Manufacturers - Specialty & Generic industry average (2.05x)
P/B vs Industry Valuation
SBFM is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more SBFM due diligence checks available for Premium users.

Be the first to know about important SBFM news, forecast changes, insider trades & much more!

SBFM News

Valuation

SBFM fair value

Fair Value of SBFM stock based on Discounted Cash Flow (DCF)
Price
$0.08
Fair Value
$1.12
Undervalued by
92.83%
SBFM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

SBFM price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.42x
Industry
48.45x
Market
42.64x

SBFM price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.38x
Industry
2.05x
SBFM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SBFM's financial health

Profit margin

Revenue
$7.7M
Net Income
-$1.3M
Profit Margin
-16.3%
SBFM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SBFM's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$27.3M
Liabilities
$6.1M
Debt to equity
0.29
SBFM's short-term assets ($24.89M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SBFM's short-term assets ($24.89M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SBFM's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SBFM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.7M
Investing
-$269.2k
Financing
-$30.5k
SBFM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SBFM vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
SBFM$7.96M-8.05%-0.42x0.38x
CLVR$7.95M-9.81%-0.40x0.33x
SHPH$6.87M-3.08%-0.93x1.69x
COSM$9.45M-3.16%-0.16x0.21x
UPC$6.27M+2.99%-1.01x0.16x

Sunshine Biopharma Stock FAQ

What is Sunshine Biopharma's quote symbol?

(NASDAQ: SBFM) Sunshine Biopharma trades on the NASDAQ under the ticker symbol SBFM. Sunshine Biopharma stock quotes can also be displayed as NASDAQ: SBFM.

If you're new to stock investing, here's how to buy Sunshine Biopharma stock.

What is the 52 week high and low for Sunshine Biopharma (NASDAQ: SBFM)?

(NASDAQ: SBFM) Sunshine Biopharma's 52-week high was $1.40, and its 52-week low was $0.04. It is currently -94.29% from its 52-week high and 81.82% from its 52-week low.

How much is Sunshine Biopharma stock worth today?

(NASDAQ: SBFM) Sunshine Biopharma currently has 99,452,865 outstanding shares. With Sunshine Biopharma stock trading at $0.08 per share, the total value of Sunshine Biopharma stock (market capitalization) is $7.96M.

Sunshine Biopharma stock was originally listed at a price of $80,800.00 in Oct 30, 2009. If you had invested in Sunshine Biopharma stock at $80,800.00, your return over the last 14 years would have been -100%, for an annualized return of -62.75% (not including any dividends or dividend reinvestments).

How much is Sunshine Biopharma's stock price per share?

(NASDAQ: SBFM) Sunshine Biopharma stock price per share is $0.08 today (as of Apr 12, 2024).

What is Sunshine Biopharma's Market Cap?

(NASDAQ: SBFM) Sunshine Biopharma's market cap is $7.96M, as of Apr 14, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Sunshine Biopharma's market cap is calculated by multiplying SBFM's current stock price of $0.08 by SBFM's total outstanding shares of 99,452,865.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.